As part of the collaboration, both companies are working together to advance the blood testing ecosystem, including BD's capillary collection technology and Babson's patented sample handling and analytical technologies
Babson, BD expand partnership to advance blood sample collection at home. (Credit: Babson Diagnostics)
Healthcare technology firm Babson Diagnostics and BD (Becton, Dickinson and Company) have extended partnership to expand blood sample collection into new care settings.
The new alliance will help patients to collect blood samples at home for diagnostic testing.
The two firms have been working together since 2019 to develop a capillary blood collection and testing technology to collect laboratory-quality, small-volume capillary blood in retail environments.
Under the expanded partnership, both firms will continue research and development for self-collection, mobile services, and at-home collection.
Babson and BD will also plan to create diagnostic tests for paediatric usage and expand the portfolio of blood tests that are possible using small-volume blood collection.
Babson Diagnostics chief executive officer David Stein said: “Today’s agreement expands our long-standing partnership with BD and builds on our shared passion of making convenient blood testing accessible to all, not only in the US, but also globally.
“Extending the medical home is critical in today’s health care environment.
“We believe that retail convenience is perfect for today’s consumer, but because the Babson service is well-suited to many settings with no need for a phlebotomist and an easier collection experience, we see many opportunities for future expansion.”
As part of the collaboration, both companies are working together to advance the blood testing ecosystem, including BD’s capillary collection technology and Babson’s patented sample handling and analytical technologies.
The two technologies intend to operate together to enable blood testing that uses a tenth of the sample volume of typical venipuncture procedures while maintaining quality and accuracy.
BD Integrated Diagnostics Solutions president Brooke Story said: “This is a paradigm-shifting solution that addresses multiple unmet needs within the current health care system.
“Because it is less invasive and more convenient than the traditional venous blood draw method, capillary blood collection may lead to an improved patient experience, which in turn could help health care providers see better compliance among patients for routine blood testing.”